Business Context and Reporting Period
Company: Greenwich LifeSciences, Inc. (GLSI)
Filing Type: Form 8-K (Current Report)
Date of Report: June 8, 2021
Reporting Period: Event date June 8, 2021; Effective date for index inclusion June 28, 2021
Business Context: The registrant is an emerging growth company incorporated in Delaware, trading on The Nasdaq Stock Market LLC.
Key Financial Metrics
This filing is a current report regarding a corporate event and does not contain financial statements. Consequently, the filing text does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity.
Material Changes
The material change reported is the announcement that Greenwich LifeSciences, Inc. will be added to the Russell 2000 and Russell 3000 Indexes. This inclusion is effective after the US markets open on June 28, 2021, following the annual reconstitution of the Russell indexes.
Guidance, Outlook, and Risks
Management Commentary: The company issued a press release (Exhibit 99.1) confirming the index inclusion.
Outlook: No specific financial guidance or operational outlook was provided in this filing.
Risks and Contingencies: No specific risks or contingencies were disclosed in this report.
Key Facts for Investor Verification
- Verify the effective date of index inclusion (June 28, 2021) against market data.
- Review the attached press release (Exhibit 99.1) for additional details on the index selection criteria.
- Confirm the company's status as an emerging growth company and its implications for financial reporting.
- Note that this filing contains no new financial performance data; refer to the most recent 10-Q or 10-K for financial metrics.